Current concepts in the development of therapeutics against human and animal coronavirus diseases by targeting NP

Area of Science:

• Virology
• Structural Biology
• Drug Discovery

Background:

• Coronaviruses (CoVs) pose significant threats to human and animal health, with recent outbreaks including SARS-CoV, MERS-CoV, and the ongoing COVID-19 pandemic caused by SARS-CoV-2.
• Despite extensive research, effective pharmaceutical interventions for coronavirus diseases remain limited.
• The viral nucleocapsid (N) protein is essential for CoV replication and presents a promising target for therapeutic development.

Purpose of the Study:

• To review current research on the biochemical and structural aspects of the coronavirus N protein.
• To identify potential N protein antagonists as broad-spectrum antiviral agents against both human and animal CoVs.

Main Methods:

• Biochemical and structural studies of the N protein.
• Cell-based assays to evaluate antiviral activity.
• Virtual screening approaches to identify N protein antagonists.

Main Results:

• The N protein's structure and function are key to developing novel inhibitors.
• Identification of potential N protein antagonists through various screening methods.
• Focus on targeting conserved regions of the N protein for broad-spectrum activity.

Conclusions:

• Targeting the coronavirus N protein offers a promising strategy for developing broad-spectrum antiviral therapies.
• Further research into N protein structure-function relationships can accelerate the discovery of effective treatments for CoV infections.
• Identifying N protein antagonists could lead to new interventions against both human and animal coronaviruses.